EcoDrugPlus

Cytidine Deaminase

Ensembl ID : ENSPTIG00000004723
Gene Symbol: CDA
2 Cross references
224 Possible Orthologues:

Cytochrome P450 Family 17 Subfamily A Member 1

Ensembl ID : ENSPTIG00000004247
Gene Symbol: CYP17A1
2 Cross references
210 Possible Orthologues:

Cytochrome P450 Family 19 Subfamily A Member 1

Ensembl ID : ENSPTIG00000007208
Gene Symbol: CYP19A1
2 Cross references
315 Possible Orthologues:

Cytochrome P450 Family 3 Subfamily A Member 131

Ensembl ID : ENSPTIG00000011625
Gene Symbol: CYP3A131
2 Cross references
672 Possible Orthologues:

Cytochrome P450 Family 3 Subfamily A Member 132

Ensembl ID : ENSPTIG00000009616
Gene Symbol: CYP3A132
2 Cross references
672 Possible Orthologues:

Cytochrome P450 Family 46 Subfamily A Member 1

Ensembl ID : ENSPTIG00000017627
Gene Symbol: CYP46A1
2 Cross references
259 Possible Orthologues:

Dihydroorotate Dehydrogenase (Quinone)

Ensembl ID : ENSPTIG00000012963
Gene Symbol: DHODH
2 Cross references
173 Possible Orthologues:

Dipeptidyl Peptidase 4

Ensembl ID : ENSPTIG00000020438
Gene Symbol: DPP4
2 Cross references
282 Possible Orthologues:

Discoidin Domain Receptor Tyrosine Kinase 2

Ensembl ID : ENSPTIG00000013569
Gene Symbol: DDR2
2 Cross references
265 Possible Orthologues:

Dopamine Receptor D1

Ensembl ID : ENSPTIG00000009485
Gene Symbol: DRD1
2 Cross references
261 Possible Orthologues:

Dopamine Receptor D2

Ensembl ID : ENSPTIG00000005980
Gene Symbol: DRD2
2 Cross references
219 Possible Orthologues:

Dopamine Receptor D3

Ensembl ID : ENSPTIG00000011530
Gene Symbol: DRD3
2 Cross references
206 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).